1 2

Tirzepen

Tirzepen 15mg

Tirzepen 15mg

Quickstart Highlights

Tirzepen 15 mg is a dual incretin receptor agonist that activates both GLP-1 and GIP receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite. Its ~5-day half-life allows convenient once-weekly subcutaneous dosing.

  1. Reconstitute: Add 6.0 mL bacteriostatic water → 2.5 mg/mL concentration.

  2. Typical weekly range: 2.5–15 mg once weekly (gradual 4-week titration steps).

  3. Easy measuring: At 2.5 mg/mL, 1 unit = 0.01 mL = 25 mcg on a U-100 insulin syringe.

  4. Storage: Freeze lyophilized powder at −20 °C; refrigerate reconstituted liquid at 2–8 °C (use within 28 days).

Dosing & Reconstitution Guide

Standard gradual approach for Tirzepen 15 mg

Standard / Gradual Approach (6 mL = 2.5 mg/mL)

Phase Weekly Dose Units (per injection)
Weeks 1–4 2.5 mg 100 units (1.0 mL) × 1 injection
Weeks 5–8 5 mg 100 units (1.0 mL) × 2 injections
Weeks 9–12 7.5 mg 100 units (1.0 mL) × 3 injections
Weeks 13–16 10 mg 100 units (1.0 mL) × 4 injections
Weeks 17–20 12.5 mg 100 units (1.0 mL) × 5 injections
Weeks 21+ 15 mg 100 units (1.0 mL) × 6 injections

Frequency: Inject once weekly subcutaneously on the same day each week. Dose increases occur every 4 weeks to minimize gastrointestinal side effects.

Reconstitution Steps

  • Draw 6.0 mL bacteriostatic water with a sterile syringe.

  • Inject slowly down the vial wall; avoid foaming.

  • Gently swirl/roll until dissolved (do not shake).

  • Label with reconstitution date and refrigerate at 2–8 °C, protected from light.

  • Use within 28 days of reconstitution.

Protocol Overview

  • Goal: Support glycemic control, weight management, and metabolic health.

  • Schedule: Weekly subcutaneous injection on the same day each week.

  • Dose Range: 2.5–15 mg weekly with 4-week titration intervals.

  • Reconstitution: 6.0 mL per 15 mg vial (2.5 mg/mL).

Dosing Protocol

  • Start: 2.5 mg once weekly for 4 weeks.

  • Escalate: Increase by 2.5 mg every 4 weeks as tolerated.

  • Maintenance: Up to 15 mg weekly based on response.

  • Timing: Any time of day; with or without food.

Storage

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions.

  • Reconstituted: Refrigerate at 2–8 °C; do not freeze liquid.

  • Shelf life: Use reconstituted solution within 28 days.

How This Works

Tirzepen is a novel dual agonist that simultaneously activates GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism enhances glucose-dependent insulin secretion while suppressing glucagon release, slowing gastric emptying, and promoting satiety through central appetite regulation. The added GIP activity appears to synergistically amplify metabolic effects beyond GLP-1 alone.

Potential Benefits & Side Effects

  • Glycemic control: Significant HbA1c reductions observed.

  • Weight reduction: Substantial body-weight loss reported in trials.

  • Cardiovascular markers: Potential improvements in lipid profiles and blood pressure.

  • Common side effects: Gastrointestinal (nausea, diarrhea, constipation) — typically mild-to-moderate.

  • Injection-site reactions: Occasional mild redness or irritation.

View full details